Loading...
New drugs approved for acute myeloid leukaemia in 2018
Acute myeloid leukaemia (AML) is a haematopoietic stem cell disorder, that is characterized by the clonal expansion of myeloid blasts and suppression of normal haematopoiesis. The 3 + 7 regimen is the backbone of standard first‐line induction therapy among young/fit patients. However, in elderly and...
Na minha lista:
| Udgivet i: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6955409/ https://ncbi.nlm.nih.gov/pubmed/31469910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14105 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|